HotSheets by Year

 

HotSheets 2010

  • Degarelix vs. Leuprolide in Advanced Prostate Cancer: Further Analysis of a Phase III Pivotal Trial
  • Us TOO Names New Board Reps for 2010
  • Dendreon Receives FDA Acknowledgement of Complete Response for Provenge BLA Resubmission
  • Doc Moyad’s “No Bogus Science” Column—Statins & Low Cholesterol “Hit Another Home Run”
  • Drug Eases ADT Side Effect in Men
  • PSA Screening Should Be Offered to Older Men
  • Read more..
  • ERSPC Study Shows PSA Screening Reduced Prostate Cancer Deaths by 20 Percent
  • PSA Velocity May Help Identify Insignificant Prostate Cancer
  • NCCN Prostate Cancer Guidelines Stress Careful Consideration of Active Surveillance
  • An Update of the Gleason Grading System
  • Coffee May Cut Risk of Prostate Cancer
  • Radiofrequency Ablation Safe and Effective for Reducing Pain from Bone Metastases
  • Ask Dr. Snuffy Myers
  • Read more..
  • Public-Private Divide in Prostate Cancer Treatment
  • Exercise May Prevent Incontinence from Prostate Cancer Surgery
  • Similar Effectiveness among Management Options for Low-Risk Prostate Cancer
  • Soy May Protect Against Prostate Cancer
  • ZERO’s ?Prostate Polar Plunge
  • Ask Dr. Snuffy Myers
  • Alternative Prostate Cancer Vaccine Shows Promise
  • Frequent Sex and Masturbation in 20s and 30s Linked to Higher Prostate Cancer Risk
  • Read more..
  • New Prostate Cancer Screening Guidelines – Commentary by Dr. Len Lichtenfeld
  • AUA Responds to Updated ACS Guidelines
  • Complex New Guidelines from Multiple Organizations Confuse Men about Prostate Cancer Screening
  • American Cancer Society – Ignorance is Bliss When it Comes to Prostate Cancer
  • Which Men Should Take Finasteride?
  • Robot-Assisted Surgery Is no Better Treatment for Prostate Cancer
  • American Cancer Society Updates Guidelines
  • Doc Moyad’s “No Bogus Science” Column – Weight Loss Supplements Are a Problem So Be Careful
  • Read more..
  • ASCO Statement on the Passage of the Patient Protection & Affordable Health Care Act
  • A Treatment for Prostate Cancer “Inadequate” Half the Time
  • Positive Results for Sanofi-Aventis Drug
  • PSA & the PSA Test: What the Public Needs to Know
  • Infertility & Prostate Cancer May Have a Common Cause
  • Ask Dr. Snuffy Myers
  • Doc Moyad’s “No Bogus Science” Column – L-Theanine Anti-Stress Amino Acid Found in Tea
  • Doctor Chodak’s Bottom Line
  • Read more..
  • FDA Approves Prostate Cancer Vaccine
  • Active Surveillance May Not Be Best Option
  • MDV3100 Shows “Substantial Activity” in Advanced Prostate Cancer
  • Radiation for Prostate Cancer Lacks Data
  • Discussing Provenge with Cancer Patients®
  • Prostate Cancer Progresses More Quickly in African-American Men
  • Ask Dr. Snuffy Myers
  • Doc Moyad’s “No Bogus Science” Column – Provenge® Receives FDA Approval
  • FDA Scrutiny of GnRH Agonists Continues
  • Degarelix Shows Promise as Second-Line Hormonal Therapy for Prostate Cancer Patients
  • Read more..
  • RT Shown Beneficial for Prostate Cancer Subset
  • Denosumab Extends Time to Bone Events
  • Us TOO Seeks Board Member Applications
  • High-Intensity Focused Ultrasound (HIFU) Non-Inferior to EBRT for Prostate Cancer
  • Cabazitaxel Benefit Confirmed in Prostate Cancer Now FDA Approved (Jevtana®, sanofi-aventis)
  • Doc Moyad’s “No Bogus Science” Column – “Exercise Ups Cialis®, Levitra® & Viagra®
  • Pelvic RT Increases Hip Fracture Risk in Men
  • Bevacizumab (Avastin®) Fails to Prolong Survival in Resistant Prostate Cancer
  • PSA Misses the Mark in Active Surveillance
  • Read more..
  • Medicare to Review Provenge® Coverage
  • Patients Face Yearlong Rationing of Provenge
  • Leather Wristbands Help Raise Awareness, Prostate Cancer Funds
  • PSA Test Does Cut Prostate Cancer Deaths
  • Cabazitaxel (Jevtana®) New Chemotherapy Approved for Advanced Prostate Cancer
  • Doc Moyad’s “No Bogus Science” Column – “Too Much Vitamin D3 Is Not a Good Thing”
  • Ask Doctor Snuffy Myers
  • Seeking Patients for New Study to Improve Prediction of Prostate Biopsy Results
  • Statins Reduce PSA Spikes After Surgery
  • Read more..
  • Immunotherapy Benefits Prostate Cancer
  • Bone Density May Predict Prostate Cancer
  • Dendreon’s $93K Price Must Be Paid by US
  • PSA Screening Can Lead to Overtreatment
  • PAF Announces Additional Support for Co-Pay Relief Program for Prostate Cancer
  • Doc Moyad’s “No Bogus Science” Column – “Too Much Folic Acid May Not Be Good”
  • Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy
  • Ask Doctor Snuffy Myers
  • Stand Up to Cancer Is Back
  • Five New Genetic Variations Linked to Prostate Cancer in Study on Japanese Men
  • Read more..
  • Oct 13 Webinar: Understanding Diagnostic Testing for Prostate Cancer Patients
  • Comorbidities May Be Key in Prostate Cancer Treatment Decisions
  • What Are Men Being Told About Their Treatment Options for Prostate Cancer
  • My Prostate Cancer Roadmap – Resource for Men with Advanced Prostate Cancer
  • Summary of Us TOO’s Summit, Symposium and 20th Anniversary Celebration
  • Abiraterone Acetate Study Unblinded after Meeting Pre-Determined Criteria
  • Ask Doctor Snuffy Myers
  • Doctor Chodak’s Bottom Line
  • Doc Moyad’s “No Bogus Science” Column – “Let’s Walk the Talk This Month!”
  • Prostate Biopsy Can Cause Urinary and Erectile Problems
  • Read more..
  • Us TOO Board Welcomes 2 New Members
  • Risk Factors for Prostate Cancer Differ Between Native and Foreign Born Black Men
  • Cabazitaxel – New Approach for Prostate Cancer
  • Protein Array Accurate for Prostate CA
  • AstraZeneca Drug Fails vs. Prostate Cancer
  • No Prostate Cancer Indication for Sunitinib
  • Us TOO Seeking Nominations for Kaps Award
  • Teva Launches Prostate Cancer Phase III Study
  • Comparing Radiation Treatments
  • POM Wonderful vs. Federal Trade Commission
  • Us TOO Seeks Board Member Applications
  • Read more..
  • Holiday Giving? Remember Us TOO
  • Drug Extends Survival in Prostate Cancer
  • Cost Should Enter Effectiveness Equation
  • Atypical Prostate Biopsy Should Be Repeated
  • Calypso Dynamic Edge Gating Technology Receives FDA 510(k) Clearance
  • PSA Test Reduces Risk of Spread if Prostate Cancer Strikes
  • VA Begins Paying Benefits for New Agent Orange Exposure
  • New Warnings on Prostate Cancer Drugs
  • Aspirin Associated with Reduced Risk of Prostate Cancer Death
  • Doc Moyad’s “No Bogus Science” Column – “Mega-Dose Vitamins”
  • Ask Doctor Snuffy Myers
  • Doctor Chodak’s Bottom Line
  • Read more..

CLICK HERE and opt-in to receive free educational emails from Us TOO.